KSC:001060
JW Pharmaceutical Corporation · KSC · Healthcare · KRW · FY for 2025
Figures on this page computed 2026-11-08 12:41 UTC
Last close
n/aKRW
Market data
8.9xP/E
Price / Earnings per Share (diluted)
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- KRW
- computed
- Computed from the filing for 2025
15.8%ROIC
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- KRW
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
8.0%Net margin
Net Income / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- KRW
- Computed from the filing for 2025
- Computed from the filing for 2025
10.9%FCF margin
Free Cash Flow / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- KRW
- Computed from the filing for 2025
- Computed from the filing for 2025
0.15Debt/equity
Total Debt / Shareholders' Equity
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- KRW
- Computed from the filing for 2025
- Computed from the filing for 2025
2.0%Dividend yield
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- KRW
- computed
Growth is the furthest below its sector's middle: 0.43 against 0.50 on the market's range.
Five bars, one line
lens 7 of 9Each against its own average
4 of 5 readExcept where said otherwise: Computed from the filing for 2025
- Sales1.27x
Its own average over 10 years, 609.99B.
- Profit4.29x
Its own average over 10 years, 14.36B.
- Free cash flow2.20x
Its own average over 10 years, 38.54B.
- Debt0.32x
Its own average over 10 years, 171.91B.
- Pricen/a
Its own average over 0 years. Market data
Profit is furthest from its own average, at 4.29 times.
Sales is 1.27 times its own 10-year average; Profit is 4.29 times its own 10-year average; Free cash flow is 2.20 times its own 10-year average; Debt is 0.32 times its own 10-year average.
Every figure in this lens
Except where said otherwise: Computed from the filing for 2025
Sales against its own 10-year average1.27
- Source
- computed
- Statement
- income
- Fiscal year
- 2025
- Reported in
- KRW
Profit against its own 10-year average4.29
- Source
- computed
- Statement
- income
- Fiscal year
- 2025
- Reported in
- KRW
Free cash flow against its own 10-year average2.20
- Source
- computed
- Statement
- income
- Fiscal year
- 2025
- Reported in
- KRW
Debt against its own 10-year average0.32
- Source
- computed
- Statement
- income
- Fiscal year
- 2025
- Reported in
- KRW
Price against its own 0-year averagen/aMarket data
Not held.
- Source
- market
- Reported in
- KRW